Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
463.00    5.00 (1.09%)
Bid:
459.00
Ask:
463.00
Spread: 4.00 (0.871%)
Market Cap: £228.60m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

FUNDS UNDER MANAGEMENT - 31 Dec 20 TRADING UPDATE

20 Jan 2021 07:00

RNS Number : 2290M
City of London Investment Group PLC
20 January 2021
 

RNS Number:

City of London Investment Group PLC

20 January 2021



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 December 2020,

TRADING UPDATE

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, announces that on a consolidated basis, as at 31 December 2020, FuM were US$11.0 billion (£8.0 billion). This compares with US$5.5 billion (£4.4 billion) at the Group's year end on 30 June 2020, which was before the merger with Karpus Management Inc ("KMI") on 1 October 2020 (the "Completion Date"). A breakdown by strategy follows:

 

 

FuM ($ million)

 

 

 

Strategy Index

 

 

 

Dec-20

Sep-20

%

 

Net

 

 

 

%

 

(estimate)

inc/dec

 

Flows

 

 

 

inc/dec

EM

5,196

4,235

23%

 

(85)

 

MSCI EM Net TR

 

19.7%

INTL

1,700

1,355

25%

 

(2)

 

MSCI ACWI ex US

 

17.0%

OV

306

268

14%

 

0

 

ACWI/Barclays Global Agg

 

8.9%

Other*

27

82

-67%

 

(63)

 

 

 

 

KMI

3,749

3,578

5%

 

(140)

 

Not applicable

 

 

 

10,978

9,518

 

 

(290)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* includes Frontier, REIT and seed investments

 

Strong investment performance across CLIG's investment strategies resulted from significant discount narrowing and to a lesser extent good NAV performance.

 

During the period under review, CLIG flows were negative as clients rebalanced following significant equity market gains, with net outflows of circa US$290 million across the Group's strategies.

 

With regard to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. 

 

Operations

 

Following the completion of the merger with KMI on 1 October 2020, the Group's income currently accrues at a weighted average rate of approximately 73 basis points of CLIM's FuM and at approximately 77 basis points of KMI's FuM, net of third party commissions. "Fixed" costs are c.£1.5 million per month, and accordingly the post-merger run-rate for operating profit, before profit-share is approximately £3.4 million per month based upon current FuM and a US$/£ exchange rate of US$1.367 to £1 as at 31 December 2020.

 

The Group estimates the unaudited profit before amortisation, exceptional items of c. £1.7 million in relation to the KMI merger and taxation for the six months ended 31 December 2020 to be approximately £11.6 million (2019: £6.3 million) and the unaudited profit before amortisation and taxation for the six months ended 31 December 2020 to be approximately £9.9 million (2019: £6.3 million).

 

Inclusive of our regulatory and statutory capital requirements, cash in the bank has risen from £14.6 million at 30 June 2020 to £17.5 million at the end of the calendar year, in addition to the seed investment of £4.1 million in the two REIT funds. Our cash reserves will allow us to continue managing the business conservatively through volatile markets while following our dividend policy for our shareholders.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2020 on 15 February 2021.

 

Dividend

 

In recognition of the improved results and having regard to the current dividend cover policy the Board has decided to increase the interim dividend by 1p to 11p per share, which will be paid on 19 March 2021 to shareholders registered at the close of business on 5 March 2021. (2019: 10 pence)

 

Dividend cover template

 

Please see dividend cover template attached here. http://www.rns-pdf.londonstockexchange.com/rns/2290M_1-2021-1-19.pdf

 

The dividend cover template shows the quarterly estimated cost of dividend against actual post-tax profits for last year, the current year and the assumed post-tax profit for next financial year based upon specified assumptions.

 

Barry Olliff's share sales

 

The Company wishes to inform that, subject to being in an open period, Barry Olliff, Founder and Director, wishes to refresh his selling intentions to sell 250,000 shares at each of 475p, 500p and 525p. In addition, the Company will no longer provide trading intentions for Mr. Olliff post 30 June 2021, which is the Company's year-end.

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUUUGUPGGRB
Date   Source Headline
29th Jun 20264:20 pmRNSPDMR Shareholding
29th Jun 20262:31 pmRNSEBT Share Purchase
24th Jun 20265:20 pmRNSEBT Share Purchase
22nd Jun 20264:51 pmRNSEBT Share Purchase
15th Jun 20263:05 pmRNSEBT Share Purchase
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.